Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : °øÁö»çÇ×
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [±â»ç]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ÆÐ³Î¾à±¹ ¸ðÁý Ȱµ¿ Àü°³
³»   ¿ë

ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ÆÐ³Î¾à±¹ ¸ðÁý Ȱµ¿ Àü°³

Á¦17ȸ ÆÊ¿¢½ºÆ÷¼­...¾à±¹ ºòµ¥ÀÌÅÍ ±¸ÃàÀ§ÇØ

2019-11-12 17:02:21 ¾öż± ±âÀÚ ¾öż± ±âÀÚ tseom@kpanews.co.kr























ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò(¼ÒÀå ¹ÚÇý°æ)°¡ Áö³­ 3ÀÏ ÁøÇàµÈ ¡®Á¦5ȸ ´ëÇѹα¹ ¾à»ç ÇмúÁ¦ ¹× Á¦17ȸ ÆÊ¿¢½ºÆ÷¡¯¿¡¼­ È¸¿øµéÀ» ´ë»óÀ¸·Î ¾à±¹ DB ±¸Ãà »ç¾÷°ú °ü·ÃÇØ Áö¿ª¾à±¹¸¸À» ´ë»óÀ¸·Î ÇÑ Á¤Ã¥¸¶·ÃÀÇ ±âÃÊÀڷḦ ¸¶·ÃÇϱâ À§ÇÑ ÆÐ³Î ¾à±¹ µî·ÏÀ» µ¶·ÁÇß´Ù. 
 
È«º¸ ºÎ½º¸¦ ¿î¿µÇÑ ¹ÚÇý°æ ¼ÒÀåÀº "¸¹Àº È¸¿øºÐµé²²¼­ ¾à±¹ DB ±¸ÃàÀÇ Çʿ伺À» °ü½ÉÀ» °®°í µî·Ï »ç¾÷¿¡ Âü¿©ÇØÁּż­ °¨»çµå¸°´Ù"¸ç "Àϼ± ¾à±¹¿¡¼­ ´À³¢´Â ¾à±¹ °ü·Ã ºòµ¥ÀÌÅÍ ±¸ÃàÀÇ Çʿ伺¿¡ ´ëÇØ ÇÔ²² ÀνÄÇØ ³ª°¡¸ç, ÇâÈÄ ¾à±¹ DB¸¦ ±¸ÃàÇÔÀ¸·Î½á ¾à±¹ ¹× ÀǾàǰ Á¤Ã¥À» À§ÇÑ ´Ù¾çÇÑ ¿¬±¸¿¡ È°¿ëÇØ ³ª°¡´Â ¹æ¾Èµé¿¡ ´ëÇØ °í¹ÎÇØ º¼ ¼ö Àִ ±âȸ°¡ µÇ¾ú´Ù"°í ¹àÇû´Ù.

À̾î "¾ÕÀ¸·Îµµ ¾à»çȸ È¨ÆäÀÌÁö³ª ¾àÇÐÁ¤º¸¿øÀÌ ¿î¿µÇϴ PhamIT3000À» ÅëÇØ Áö¼ÓÀûÀΠµî·Ï Ã¢±¸¸¦ ¸¶·ÃÇϰí ÀÌ¿¡ ´ëÇÑ È«º¸¸¦ ÅëÇØ ÆÐ³Î ¾à±¹ ¸ðÁý È°µ¿À» Áö¼ÓÇØ ³ª°¡°Ú´Ù"°í ¼³¸íÇß´Ù. 
 
¿¬±¸¼Ò´Â ³»³â¿¡´Â ´ëÇ¥¼ºÀ» °í·ÁÇØ ¼±Á¤µÈ ¾à±¹À» ´ë»óÀ¸·Î º» »ç¾÷¿¡ ´ëÇÑ ÃëÁö¿Í Âü¿©¹æ¹ý¿¡ ´ëÇÑ ±³À°À» ½Ç½ÃÇϰí, µ¥ÀÌÅÍ ÃßÃâ ¹× Àü¼ÛÀ» À§ÇÑ S/W °³¹ß ¹× ¹èÆ÷, ½ÃÇè ¿î¿ë µîÀ» °ÔȹÇϰí ÀÖ´Ù.    
 
ÀÌ ¹Û¿¡µµ À̳¯ È«º¸ ºÎ½º¿¡¼­´Â ¿¬±¸¼Ò°¡ ÃßÁøÇϴ ´Ù¾çÇÑ ¿¬±¸ »ç¾÷ ¹× °úÁ¦µéÀ» ¼Ò°³Çϴ ÇÑÆí, ¾à»ç ÇмúÁ¦¿¡ Âü¿©ÇÑ ¾à»çµéÀ» ´ë»óÀ¸·Î´Â ¿¬±¸¼Ò°¡ ¼öÇà ÁßÀΠ'¾î¸°ÀÌ ÀǾàÁ¤º¸ Á¦°ø ¹× È«º¸¡¹ »ç¾÷À» À§ÇØ Á¦ÀÛÇÑ ±³À°¿ë ¸®Ç÷¿À» ¹èÆ÷Çß´Ù. 

ÇÑÆí ¿¬±¸¼Ò´Â ÃÖ±Ù ¾à»ç°ø·Ð Áö¸éÀ» ÅëÇØ 'Áֿ䠿ܱ¹ÀÇ ¾à±¹°æ¿µ ¹× ÀǾàǰ »ç¿ë °ü·Ã ¾à±¹ DB ±¸Ãà ÇöȲ°ú ½Ã»çÁ¡'¿¡ ´ëÇØ ¼Ò°³ÇÑ ¹Ù ÀÖ´Ù.


 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
168 û³â¾à»ç¿Í ¾à´ë»ýÀ» À§ÇÑ Ä¿¸®¾î °³¹ß °¡À̵åºÏ ÃÖÀ±Á¤ 2022-02-14 2540
167 2020³â ±âºÎ±Ý ¸ðÁý ¹× ÁöÃâ ¸í¼¼¼­ ÀÌÁö¿¬ 2021-05-10 1485
166 [ȯÀÚ¾ÈÀü º¸°íÇнÀ ½Ã½ºÅÛ] '¾à±¹ ¾àÁ¦¾÷¹« °ü¸®Áöħ ¾È³»' °Ô½Ã ±èÁøÀÌ 2020-06-25 3601
165 2021 ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¿¬±¸¿ø ä¿ë °ø°í °ü¸®ÀÚ 2020-03-12 6739
164 [´ëÇѾà»çÀú³Î] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®_Á¶±â´ëÀÀü°è¿¡ ÃÖÀûÈ­µÈ ¡®¾à±¹±â¹Ý °¨½Ã ½Ã½ºÅÛ¡¯ ±è¼±Èñ 2020-02-26 3591
163 [´ëÇѾà»çÀú³Î] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®_Äڷγª19 ´ëÀÀ FIP ½Å±Ô °¡À̵å¶óÀÎ ±è¼±Èñ 2020-02-26 3172
162 [´ëÇѾà»çÀú³Î] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®_¼¼°è ¾à±¹µéÀÇ °¨¿°¼º Áúȯ °¨½Ã ¹× ´ëÀÀ »ç·Ê ¼Ò°³ 1Æí ±è¼±Èñ 2020-02-12 2068
161 "¾à·á»ç¾÷ ³Ñ¾î Áö¿ª Á᫐ ¾à±¹ °Ç°­Çãºê ¿ªÇÒ Èû¾µ °Í" ±è¼±Èñ 2020-01-30 1668
160 "¾à±¹ '°Ç°­ÁõÁø Çãºê' ¹æÇâÀ¸·Î °¡¾ß"...·¹Áö½ºÆ®¸® ±¸Ãà º»°ÝÈ­ ±è¼±Èñ 2020-01-30 1478
159 [´ëÇѾà»çÀú³Î/ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®]¿µ±¹ ¾à±¹, °Ç°­ »ýȰ ¼¾ÅÍ·Î ¹ßµ¸¿ò ±è¼±Èñ 2020-01-30 1667
158 [´ëÇѾà»çÀú³Î/ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®]È£ÁÖ, ¹æ¹® ¾à·á µµÀÔÇØ ¾à¹° ¿ä¹ý ÇýÅà ±Ø´ëÈ­ ±è¼±Èñ 2020-01-30 1380
157 [´ëÇѾà»çÀú³Î/ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®]ÀϺ», ¡®´Ü°ñ¾à»ç-ÀçÅù湮¿Ï·á¡¯ È£Æò ¼Ó Ȱ¼ºÈ­ ±è¼±Èñ 2020-01-30 1472
156 [´ëÇѾà»çÀú³Î/ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®]±¹³»¿Ü »ç·Ê°íÂûÀ» ÅëÇÑ Ä¿¹Â´ÏƼ Äɾ¼­ÀÇ Áö¿ª¾à±¹ ¹× ¾à»ç ¿ªÇÒ Å½»ö 1 ±è¼±Èñ 2020-01-30 1372
155 [±â»ç]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ÆÐ³Î¾à±¹ ¸ðÁý Ȱµ¿ Àü°³ ±è¼±Èñ 2019-11-13 1537
154 [±â»ç]¾à±¹¸¸ÀÇ Ã¼°èÀû Á¤Ã¥¼ö¸³À§ÇÑ ¾à±¹DB ±¸Ãà 'ù¹ß' ±è¼±Èñ 2019-11-13 1443

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»